High-dose statin before percutaneous coronary intervention lowers risk of periprocedural myocardial infarction and 30-day major cardiac adverse events

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)13-14
Number of pages2
JournalEvidence-Based Medicine
Volume17
Issue number1
DOIs
StatePublished - Feb 2012
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this